JNJ-61178104

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-61178104, covering 2017-01-23 to 2017-01-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety and Tolerability of JNJ-61178104 in Healthy Participants [Phase 1]